The XLGB capsule is an OTC drug that has been approved by the China Food and Drug Administration (CFDA) for the treatment of osteoarthritis, osteoporosis, aseptic osteonecrosis, and bone fracture. It has been used clinically for over 15 years and has demonstrated its efficacy and safety for the prevention of postmenopausal osteoporosis.
In addition to its use in treating osteoarthritis and osteoporosis, the XLGB capsule has also been shown to have preventive effects on primary Osteoarthritis (OA) by inhibiting bone loss. Emerging evidence suggests that the course of primary OA is associated with osteoporosis, especially at subchondral bone. Therefore, the XLGB capsule may also have preventive effects on OA prevention via inhibition of bone loss.
The XLGB capsule is a herbal Fufang product that is designed to help prevent the development of OA and maintain healthy bone density. The product is made from a combination of natural ingredients that have been shown to have anti-inflammatory and bone-strengthening properties.
The efficacy and safety of the XLGB capsule for the treatment of OA and the prevention of postmenopausal osteoporosis have been demonstrated through clinical trials. The product is available over-the-counter and can be taken as a dietary supplement to help maintain healthy bone density.
Overall, the XLGB capsule is a safe and effective solution for those looking to prevent the development of OA and maintain healthy bone density. With its long history of clinical use and demonstrated efficacy, the product is a reliable choice for those looking to manage their OA symptoms and prevent further damage to their bones.